Log in
Enquire now
Anaveon

Anaveon

Anaveon is a company founded in 2017.

OverviewStructured DataIssuesContributors

Contents

anaveon.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Manufacturing
Manufacturing
Health technology
Health technology
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Immunotherapy
Immunotherapy
Engineering
Engineering
Location
Basel
Basel
0
Switzerland
Switzerland
B2X
B2B
B2B
CEO
Pitchbook URL
pitchbook.com/profiles...265667-14
Number of Employees (Ranges)
11 – 50
Email Address
onur.boyman@anaveon.com
contact@anaveon.com0
julia.wilson@anaveon.com0
Full Address
Technologiepark Basel Hochbergerstrasse 60C 4057 Basel, Switzerland0
Investors
Novartis Venture Fund
Novartis Venture Fund
Forbion Capital Partners
Forbion Capital Partners
Pontifax Venture Capital
Pontifax Venture Capital
Pfizer Venture Investments
Pfizer Venture Investments
‌
Cowen Healthcare Investments
Founded Date
January 1, 2017
Total Funding Amount (USD)
155,000,000
Latest Funding Round Date
December 16, 2021
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
Switzerland
Switzerland

Other attributes

Latest Funding Round Amount (USD)
120,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Anaveon

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.